000 | 01934 a2200517 4500 | ||
---|---|---|---|
005 | 20250516171126.0 | ||
264 | 0 | _c20140213 | |
008 | 201402s 0 0 eng d | ||
022 | _a1097-685X | ||
024 | 7 |
_a10.1016/j.jtcvs.2013.07.043 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBell, Marshall T | |
245 | 0 | 0 |
_aDexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion. _h[electronic resource] |
260 |
_bThe Journal of thoracic and cardiovascular surgery _cJan 2014 |
||
300 |
_a500-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdrenergic alpha-2 Receptor Agonists _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta, Thoracic _xsurgery |
650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xmetabolism |
650 | 0 | 4 |
_aCREB-Binding Protein _xmetabolism |
650 | 0 | 4 | _aConstriction |
650 | 0 | 4 |
_aDexmedetomidine _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-2 _xdrug effects |
650 | 0 | 4 |
_aReperfusion Injury _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
650 | 0 | 4 |
_aSpinal Cord Ischemia _xmetabolism |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aPuskas, Ferenc | |
700 | 1 | _aBennett, Daine T | |
700 | 1 | _aHerson, Paco S | |
700 | 1 | _aQuillinan, Nidia | |
700 | 1 | _aFullerton, David A | |
700 | 1 | _aReece, T Brett | |
773 | 0 |
_tThe Journal of thoracic and cardiovascular surgery _gvol. 147 _gno. 1 _gp. 500-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jtcvs.2013.07.043 _zAvailable from publisher's website |
999 |
_c23087631 _d23087631 |